VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
46,870MODERNA
532GLAXOSMITHKLINE BIOLOGICALS
353PFIZER\BIONTECH
231MERCK & CO. INC.
221UNKNOWN MANUFACTURER
62SEQIRUS, INC.
25DYNAVAX TECHNOLOGIES CORPORATION
13EMERGENT BIOSOLUTIONS
12SANOFI PASTEUR
9NOVARTIS VACCINES AND DIAGNOSTICS
5PFIZER\WYETH
5PAXVAX
2TEVA PHARMACEUTICALS
2PROTEIN SCIENCES CORPORATION
1BERNA BIOTECH, LTD.
1INTERCELL AG
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL1,906
1,575
289
IMM209286
252
236
229
s029456178
171
UT7065MA166
155
149
145
S034636133
107
U62828AA103
100
98
P10025327596
U6737AA85
UJ446AA79
78
78
59
57
4BH3254
4F47253
52
27656352
50
PP9L548
49TM346
42
40
38
MENVEO38
4F47237
R1B252M36
34
C5763AA30
93362229
25
300057A24
UNK24
22
CW311621
18
17
15
UH894AB15
3Y7NL12
R1B743M12
EJ168611
el128410
10
10
10
9
ARBA141A9
UNK9
8
UNK8
8
1F4EB8
Unknown7
7
No batch number6
5
5
UJ090AA5
5
5
4
4
4
UNK4
JEV18K95E4
UNK3
A115A3
Z127A3
3
3333324181073
2
2
2
TAR352
1
1
1
1
1
A739081
1
1
1
1
1
037K20A68,542
EL128447,700
133

Incidents per State

State Total
15,185
CA14,096
NY7,507
TX7,196
FL6,939
IN5,527
PA4,560
IL4,179
OH4,054
AZ3,856
MI3,771
NJ3,411
MA3,278
VA3,208
NC3,114
WA3,034
GA2,864
MD2,652
MN2,534
CO2,532
WI2,457
MO2,029
OR1,943
TN1,715
CT1,693
KY1,603
OK1,226
AL1,201
KS1,162
IA1,157
SC1,106
NM1,065
UT973
AR951
LA945
NE829
NV797
ME795
MT789
NH756
ID674
AK661
WV661
PR650
MS585
HI536
RI510
VT441
SD361
ND356
DE350
DC239
WY209
GU32
AS16
VI13
MP9
MH3
FM2
QM1
XB1

ID: 1061993
Sex: M
Age:
State:

Vax Date: 01/26/2021
Onset Date: 01/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: Test Name: temperature; Result Unstructured Data: Test Result:38 Centigrade; Comments: high temperature, fever

Allergies:

Symptoms: chills; high temperature/fever 38 C; feeling tired; headache; This is a spontaneous report from a contactable consumer (the patient). A male patient of an unspecified age received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number not provided), via an unspecified route of administration on 26Jan2021 (age at vaccination unknown) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received the second dose of the vaccine yesterday 26Jan2021. He experienced chills, high temperature/fever 38 C, feeling tired, and headache the day after (27Jan2021). The patient took paracetamol (TYLENOL) to manage the symptoms. He asked if these are normal side effects and was looking for recommendations. The clinical outcome of chills, high temperature/fever 38 C, feeling tired, and headache was unknown. Information about Lot/batch number requested.

Other Meds:

Current Illness:

ID: 1061994
Sex: F
Age:
State: CT

Vax Date: 01/26/2021
Onset Date: 01/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: very sore arm; very uncomfortable; This is a spontaneous report from a contactable consumer. An adult female patient received bnt162b2 (Pfizer-BioNTech COVID-19 vaccine), via an unspecified route of administration on 26Jan2021 at a single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient is not pregnant at the time of vaccination. On 27Jan2021, the patient experienced very sore arm- had to have vaccine in dominant arm. The patient added that after 24 hours she was very uncomfortable. The events were assessed non-serious. The patient has not been diagnosed with Covid prior to vaccination and has not tested positive since the vaccination. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1061995
Sex: F
Age:
State: FL

Vax Date: 01/11/2021
Onset Date: 01/15/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Burning right arm; fatigue; This is a spontaneous report from a contactable other healthcare professional (patient). A 36-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration on the left arm on 11Jan2021 09:30 at a single dose for COVID-19 immunization. The patient had no medical history. There were no concomitant medications. On 15Jan2021, the patient experienced burning right arm and fatigue. Treatment was received for the adverse events which included MRI, NCS, Blood work. The events resulted to a doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. Events were reported as non-serious: did not result in death, was not life-threatening, did not cause/prolonged hospitalization, was not disabling/incapacitating and did not cause congenital anomaly/birth defect. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There were no other medications the patient received within 2 weeks of vaccination. Patient was not pregnant. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1061996
Sex: F
Age:
State: NY

Vax Date: 01/26/2021
Onset Date: 01/01/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: nervousness; slight swelling/tingling in lips; slight swelling/tingling in lips; dizziness; like she has a cough in her throat; swelling and soreness of her arm; swelling and soreness of her arm; Tightness in her jaw; Numbness in hand; difficulty swallowing; taste in her mouth; dry mouth; This is a spontaneous report from a contactable consumer (patient). A 70-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot number: EL3247, unknown expiration), via an unspecified route of administration in left arm on 26Jan2021 at 08:30 AM at a single dose for COVID-19 immunization in a clinic. Medical history included ongoing underactive thyroid, cataract surgery on 14Oct2020 and on 28Oct2020, and cholesterol (abnormal). Concomitant medications included ongoing levothyroxine for underactive thyroid and ongoing rosuvastatin calcium for cholesterol. The patient experienced nervousness, slight swelling/tingling in lips, dizziness, like she has a cough in her throat, swelling and soreness of her arm, tightness in her jaw, numbness in hand on 26Jan2021. The patient also had difficulty swallowing, had taste in her mouth, and dry mouth in Jan2021. The patient on the line calling about the COVID-19 vaccine. She got the shot yesterday (26Jan2021) and was calling to report on the reaction that occurred. She initially stated she had slight swelling/tingling in lips, difficulty swallowing, numbness in hands, jaws became tight, and nervousness which she is still experiencing. She mentioned she took benadryl. She was wondering if she should go and get the second shot. The patient first experienced dizziness which lasted for a second and this occurred while waiting in the lobby for observation after getting the vaccine. Slight swelling and tingling in lips were noticed two minutes after the dizziness. It felt like a tingle sensation. She clarified she does not necessarily have difficulty swallowing. It was not so much she could not swallow, but it was like she has a cough in her throat. It feels like she could cough but would need to keep swallowing and drinking water. Once she got the shot it caused her to get a taste in her mouth. The feeling like a cough in her throat has gone away, but now she feels nervousness, dry mouth, and she still has that taste in her mouth from getting the shot. She had swelling and soreness of her arm, but she knew that was to be expected which started an hour after getting the vaccine. Tightness in her jaw was noticed an hour after getting the vaccine. The numbness in hand started at the same time as the tightness of her jaw. Her left hand is what went numb, and she had the vaccine administered in her left arm. The nervousness is getting better, but she felt very nervous. She also mentioned she has thyroid problems and is not sure if this has anything to do with it. She had this nervousness feeling 2 hours after getting the shot. Patient is scheduled to get the second vaccine on 18Feb2021. Benadryl has helped a lot. The patient has no additional vaccines administered on the same date and has no prior vaccination within four weeks. The events did not require emergency room and physician office visit. Vaccine was not administered in a military facility. The patient was recovering from events nervousness, slight swelling/tingling in lips, swelling and soreness of her arm, tightness in her jaw, and numbness in hand; recovered from dizziness on 26Jan2021; recovered from event "like she has a cough in her throat" on unspecified date; not yet recovered from event "taste in her mouth"; while unknown outcome for the remaining events. No follow-up attempts are possible. No further information is expected.

Other Meds: LEVOTHYROXINE; ROSUVASTATIN CALCIUM

Current Illness: Thyroid function decreased

ID: 1061997
Sex: F
Age:
State: FL

Vax Date: 01/14/2021
Onset Date: 01/14/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Body aches/random shooting pains throughout body; Fatigue; Upper back pain; abdominal pain; severe coughing that evening; headache; very sore arm; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number:EK9231), via an unspecified route of administration on the right arm on 14Jan2021 08:30 at a single dose for COVID-19 immunization at a hospital. Medical history included very chemically sensitive and drug sensitive, interstitial lung disease, and interstitial cystitis. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. Concomitant medication included vitamin D, zinc, and an unspecified thyroid medication. On 14Jan2021 13:00, the patient experienced body aches, fatigue, random shooting pains throughout body, upper back pain, abdominal pain, severe coughing that evening, headache, and very sore arm. Treatment included self prescribed paracetamol (TYLENOL). Since the vaccination, the patient has not been tested for COVID-19. The patient has not yet recovered from the events.

Other Meds: VITAMIN D NOS; ZINC

Current Illness:

ID: 1061998
Sex: F
Age:
State: NV

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Itchy neck, arms, lower half of face; Hives on both arms.; Burning headache; This is a spontaneous report from a contactable consumer (patient). A 39-year-old female patient received first dose of bnt162b2 (Pfizer-BioNTech COVID-19 vaccine; lot number: EL8982), via an unspecified route of administration in the right arm on 27Jan2021 08:45 at a single dose for covid-19 immunization. Medical history included hypothyroid, allergies to nausea medication and COVID 19. Concomitant medication included levothyroxine. On 27Jan2021 12:00, the patient experienced itchy neck, arms, lower half of face., hives on both arms and burning headache. The patient did not receive treatment for the events. The events were assessed non-serious. The outcome of the events was not recovered.

Other Meds: LEVOTHYROXINE

Current Illness:

ID: 1061999
Sex: F
Age:
State: NY

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: Test Date: 20210126; Test Name: Body temperature; Result Unstructured Data: Test Result:Fever

Allergies:

Symptoms: Chills, fever, muscle aches and nauseous. Vomited twice; Chills, fever, muscle aches and nauseous. Vomited twice; Chills, fever, muscle aches and nauseous. Vomited twice; Chills, fever, muscle aches and nauseous. Vomited twice; Chills, fever, muscle aches and nauseous. Vomited twice; This is a spontaneous report from a contactable Other Health Professional that reported for herself. A 25 year old female patient received dose 2 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EL9262 on 26Jan2021 09:00, as single dose (at the age of 25 years) via unspecified route in left arm for COVID-19 immunisation. The patient medical history was not reported. Concomitant medication includes fluoxetine (FLUOXETINE). Historical vaccine included dose one of BNT162B2, lot number EL0142, on 07Jan2021 11:30, unspecified route, vaccine location Left arm for COVID-19 immunization. The patient did not have Allergies to medications, food, or other products. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive other vaccines within 4 weeks prior to the COVID vaccine. On 26Jan2021 at 20:00 the patient experienced chills, fever, muscle aches and nauseous. The patient vomited twice. No treatment was given. The patient is recovering from Chills, fever, muscle aches and nauseous as well as vomited twice. The case was reported as non-serious by the reporter.

Other Meds: FLUOXETINE

Current Illness:

ID: 1062000
Sex: F
Age:
State: OH

Vax Date: 01/22/2021
Onset Date: 01/26/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Rash face and neck; This is a spontaneous report from a contactable Other Health Professional that reported for herself. A 53-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) Lot number EL8982 on 22JAN2021 15:00, as single dose (at the age of 53 years) via unspecified route in left arm for COVID-19 immunisation. The patient medical history was none. Concomitant medication was not reported. The patient was not pregnant at the time of vaccination. There were no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient has not been tested for COVID-19. On 26Jan2021 at 06:00 the patient experienced Rash face and neck. The patient received treatment (Benadryl and aloe). The outcome rash face and neck are recovering. The case was reported as non-serious by the reporter.

Other Meds:

Current Illness:

ID: 1062001
Sex: F
Age:
State: FL

Vax Date: 01/20/2021
Onset Date: 01/20/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Eyes bloodshot; Rash over entire body...arms, legs, abdomen, back, neck; dose number= 1, administration date= 06Jan2021/dose number= 2, administration date=20Jan2021; dose number= 1, administration date= 06Jan2021/dose number= 2, administration date=20Jan2021; This is a spontaneous report from a contactable nurse (patient). A 61-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular at the left arm on 20Jan2021 07:45 at single dose for COVID-19 immunization. Medical history included hypothyroidism. The patient was not pregnant at the time of vaccination. Concomitant medication included thyroid (WP THYROID), methocarbamol, and paracetamol (TYLENOL). The patient has known allergies to cefalexin (KEFLEX) and statins. The patient was previously vaccinated with the first dose of BNT162B2 on 06Jan2021 07:45 at the age of 61-year-old intramuscular at the right arm for COVID-19 immunization. The patient experiences rash over entire body, arms, legs, abdomen, back, neck, not on the face yet and eyes bloodshot; symptoms appeared over 8-hour period beginning at 7 am on 26Jan2021. The patient did not receive any treatment for the events. The outcome of the events rash over entire body and eye bloodshot were not recovered.

Other Meds: WP THYROID; METHOCARBAMOL; TYLENOL

Current Illness:

ID: 1062002
Sex: F
Age:
State: NC

Vax Date: 01/25/2021
Onset Date: 01/26/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: fingers were numb and tingling; 12 hours post 2nd dose the left side of patient face and left ear were numb as well as both arms and both legs/fingers were numb and tingling; This is a spontaneous report from a contactable consumer. A 23-year-old female patient (not pregnant) received the second dose of bnt162b2 (BNT162B2 also reported as BIONTECH Covid vaccine, lot EL3247), via an unspecified route of administration in the left arm on 25Jan2021 at SINGLE DOSE for Covid-19 immunisation. The patient's medical history was not reported. There were no concomitant medications. She received her first dose of bnt162b2 (lot EK9231) on 05Jan2021 in the left arm. On 26Jan2021, the left side of patient's face and left ear were numb as well as both arms and both legs and 800mg of ibuprofen was taken. Next morning (27Jan2021), the numbness in legs gone but the left arm from shoulder to fingers were numb and tingling. The outcome of events was recovered.

Other Meds:

Current Illness:

ID: 1062003
Sex: F
Age:
State: CA

Vax Date: 12/26/2020
Onset Date: 12/01/2020
Rec V Date: 03/01/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: patient with myelitis transverse received Pfizer Covid 19 vaccine; patient with myelitis transverse received Pfizer Covid 19 vaccine; Paresthesias to bilateral hands to elbows, right foot/leg; brain fog; fatigue; This is a spontaneous report from a contactable nurse (patient). A 39-year-old female patient received her first dose of bnt162b2 (BNT162B2 reported as PFIZER COVID 19 VACCINE; lot number: EK-5730; expiration date: unknown) at 39-year-old age of vaccination intramuscularly in the left arm on 26Dec2020 11:30 at a single dose for covid-19 immunization. Medical history included myelitis transverse from 2015 to an unknown date and depression. The patient has no known allergies. The patient was not diagnosed with covid-19 prior to vaccination. The patient did not receive other vaccine in four weeks but has other medications in two weeks. It was reported that the patient with myelitis transverse received Pfizer Covid 19 vaccine on 26Dec2020. On Dec2020, the patient had paresthesias to bilateral hands to elbows, right foot/leg with brain fog and fatigue. Symptoms appeared approximately 12-18hrs after injection. There was no treatment receive for the adverse events. The events resolved 48 hours after. The adverse events resulted in a doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient underwent lab tests and procedures which included nasal swab (sars-cov-2 test) with the result of negative on 22Jan2021. The outcome of the events was recovered on Dec2020.

Other Meds:

Current Illness:

ID: 1062004
Sex: F
Age:
State: WI

Vax Date: 01/25/2021
Onset Date: 01/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: she has a hearing problem; Constant chills; Cramps; Diarrhea; Nausea; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: EL3248) via an unspecified route of administration on 25Jan2021 10:30 on the left arm at a single dose for COVID-19 immunization. The patient had no medical history. There were no concomitant medications. The patient stated that she did not experience any problems until 27Jan2021 around noon, in which she started experiencing chills, cramps, and diarrhea all afternoon. She would like to know if these reactions have been reported and if they continue to persist, can she take something like Imodium. She didn't have any effect at all from it on Monday or Tuesday, and at noon on 27Jan2021, she had nausea and constant chills and diarrhea, she doesn't think this was a side effect, but wanted to check and see. She was not terribly ill, just uncomfortable, is this something she should be reporting? Stated she has a hearing problem, wished for DSU agent to speak slower. Nausea: was off and on all the time since noon today, it is better, the main thing is diarrhea, and the nausea is connected Constant chills: improving, it came and went all afternoon, she doesn't know if it has gone away, she thinks it is still here, but she is not constantly bothered, it has been periodically since noon today. Diarrhea: better since she has nothing left; nothing was getting worse, she was reporting it because she thought it may be a side effect. Outcome of the events constant chills and nausea was recovering, diarrhea was recovered on an unspecified date while unknown for the other events.

Other Meds:

Current Illness:

ID: 1062005
Sex: F
Age:
State:

Vax Date: 01/07/2021
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Tongue and throat swelling; Tongue and throat swelling; not able to breathe; right and left sided face swelling; hives from top of head to lower extremities; This is a spontaneous report from a contactable consumer (patient). A 67-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3248), via an unspecified route of administration on 07Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced tongue and throat swelling and took diphenhydramine (BENADRYL). Patient was also not able to breathe, had right and left sided face swelling, and hives from top of head to lower extremities. Patient reported that the doctor gave her an epi pen. Patient would like to know if she should get second dose. She is scheduled to receive second dose on 28Jan2021 also if she should get a pneumonia vaccine and was instructed to wait 14 days after the Pfizer Biotech Covid-19 vaccine administration. Outcome of the events was unknown.

Other Meds:

Current Illness:

ID: 1062006
Sex: F
Age:
State: MN

Vax Date: 01/19/2021
Onset Date: 01/21/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swelling in the area of eyes and cheeks of previously administered dermal fillers (dermal fillers injected around Jun20) and pain, some redness; Swelling in the area of eyes and cheeks of previously administered dermal fillers (dermal fillers injected around Jun20) and pain, some redness; Swelling in the area of eyes and cheeks of previously administered dermal fillers (dermal fillers injected around Jun20) and pain, some redness; Swelling in the area of eyes and cheeks of previously administered dermal fillers (dermal fillers injected around Jun20) and pain, some redness; This is a spontaneous report from a contactable nurse (patient). A 53-year-old female patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, lot number: EL3247, unknown expiration), via an unspecified route of administration in right arm on 19Jan2021 at a single dose for COVID-19 immunization in a workplace clinic. Medical history included hypothyroidism, idiopathic thrombocytopenic purpura (ITP), and previously administered dermal fillers in Jun2020. The patient has no allergies to medications, food, or other products. Concomitant medications included levothyroxine, tamoxifen, and vitamin D. The patient also received her first dose of BNT162B2 (lot number: EJ1685, unknown expiration) for COVID-19 immunization in right arm on 29Dec2020. The patient experienced swelling in the area of eyes and cheeks of previously administered dermal fillers (dermal fillers injected around Jun20) and pain, some redness on 21Jan2021. The patient received steroids and antihistamines. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19 prior to vaccination and has not been tested for COVID-19 since the vaccination. The patient recovered from the events on unspecified date. The events were assessed as non-serious. No follow-up attempts are possible. No further information is expected.

Other Meds: LEVOTHYROXINE; TAMOXIFEN; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1062007
Sex: F
Age:
State: NY

Vax Date: 01/18/2021
Onset Date: 01/20/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Intense Itching and swelling; Intense Itching and swelling; Pain but not severe, moderate; This is a spontaneous report from a contactable consumer (patient). A 65-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL 3247), via an unspecified route of administration on 18Jan2021 17:30 at a single dose on left arm for COVID-19 immunization. Medical history included itchiness from fake eyelash glue. There were no concomitant medications. The patient previously received flu vaccine for immunization and experienced itchiness. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and no any other medications received within 2 weeks of vaccination. The patient was not pregnant at the time of vaccination. On 20Jan2021, the patient experienced intense itching and swelling and pain but not severe, moderate. The events resulted in visit to emergency room/department or urgent care. The patient was treated with antihistamine for the events. The patient was recovering from the events. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, the patient has not been tested for COVID-19. The events were reported as non-serious.

Other Meds:

Current Illness:

ID: 1062008
Sex: F
Age:
State: CA

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: covid test (Nasal Swab/Rapid Antigen); Test Result: Negative

Allergies:

Symptoms: Just a lot of soreness. After 2 hours I began to have a lot of pain; I was even having trouble raising my arm up because of the pain/soreness; I was even having trouble raising my arm up because of the pain/soreness; This is a spontaneous report from a contactable healthcare professional (patient). A 22-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot EL8982), intramuscular on 21Jan2021 10:00 at single dose (left arm) for covid-19 immunization. The patient medical history was not reported. The patient had no allergies to medications, food or other products and patient was not pregnant. There were no concomitant medications. On 21Jan2021, 12:00, the patient experienced a lot of soreness. After 2 hours, she began to have a lot of pain for the rest of the day. That same night, she was even having trouble raising her arm up because of the pain/soreness, but by the next day the soreness went a lot more down. There was no therapy for the events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine and had no other medications received within 2 weeks of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient underwent lab tests and procedures which included Sars covid test (Nasal Swab/Rapid Antigen) was negative on 22Jan2021. Outcome of events was recovered on an unspecified date.

Other Meds:

Current Illness:

ID: 1062009
Sex: M
Age:
State: FL

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Patchy red skin on both thighs. Slightly itchy.; Patchy red skin on both thighs. Slightly itchy.; This is a spontaneous report from a contactable consumer. A 76-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot and expiry not reported), via an unspecified route of administration on 21Jan2021 at 09:45 at a single dose on left arm for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced patchy red skin on both thighs, slightly itchy on 21Jan2021. Therapeutic measures were taken as a result of both events (steroid cream). The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1062010
Sex: F
Age:
State: FL

Vax Date: 01/19/2021
Onset Date: 01/20/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: She started experiencing burning; Rash; Shingles; itching; Headache; Malaise; very tired; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported that a 71-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: E13247) via an unspecified route of administration on 19Jan2021 11:30 at a single dose for COVID-19 immunization. Medical history included A-fib. Concomitant medication included apixaban (ELIQUIS). Had COVID-19 Vaccine on 19Jan2021 and everything was fine. Had a headache and a little bit of malaise on 20Jan2021. After two days was ok. On 21Jan2021, broke out in what she thinks was shingles. Not 100% sure if it was a major rash or shingles. Wanted to know if that was a possible side effect. Patient was taking Valaciclovir (VALTREX) for Shingles. Doctor suspected it was shingles, but it was possible she had shingles brewing before the COVID-19 Vaccine or the COVID-19 Vaccine brought the shingles out. Second COVID-19 Vaccine is scheduled for 09Feb2021, patient was scared and afraid of it. Doesn't know what to do. On 20Jan2021 she was very tired and had a headache. Next day was ok. On 21Jan2021 thought she had bug bites. Started itching. Then it began traveling and she realized it was not bug bites. She started experiencing burning. Went to two Urgent Care and her Internist. Was told it was basically shingles. Her internist was on the fence because she just had the COVID-19 Vaccine and wasn't certain. Caller stated it was ironic that she broke out after the vaccine. Caller's internist stated for any rash it would be treated the same with Valtrex. Internist stated chances were the rash was viral so if it's not shingles, would be treated with Valtrex. Rash and Itching: Wasn't very bad on Saturday, 23Jan2021, which was the first time she had someone look at it. On Sunday, 24Jan2021 it was full blown and really blossomed. Was initially treating rash as if it was bug bites. Was applying Benadryl tropical. On Sunday, 24Jan2021, started taking Valtrex. Outcome of the events headache, malaise, fatigue was recovered on n unspecified date, while unknown for the other events.

Other Meds: ELIQUIS

Current Illness:

ID: 1062011
Sex: M
Age:
State: CA

Vax Date: 01/14/2021
Onset Date: 01/17/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: Test Date: 20210125; Test Name: Nasal Swab/SARS-CoV-2 RNA Real Time RT PCR; Test Result: Negative

Allergies:

Symptoms: heart palpitations; shortness of breath; This is a spontaneous report from a contactable consumer (patient). A 54-year-old male patient received the 1st dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Lot number: Unknown), via an unspecified route of administration at the left arm on 14Jan2021 at a single dose for COVID-19 immunization. The vaccine was administered in a Nursing Home/Senior Living Facility. The patient had no medical history. The patient had not received other vaccine in four weeks. Concomitant medication included erythromycin eye ointment. On the 17Jan2021 4PM, 3 days after being vaccinated the patient got heart palpitations and shortness of breath. This continued until the 23Jan2021 when he stopped having the heart palpitations. However, the shortness of breath has continued. It started out as light shortness of breath and has evolved into moderate. He was not gasping for air but it was uncomfortable enough where he has had to take time off of work. He was seen by a doctor on 27Jan2021. The patient did not receive any treatment for the event. The patient had Nasal swab/ SARs CoV-2 RNA Real time RT PCR on 25Jan2021, and the result was negative. The outcome of the event heart palpitations was recovered on 23Jan2021 and shortness of breath was not recovered. Information on lot number/batch number has been requested.

Other Meds: ERYTHROMYCIN

Current Illness:

ID: 1062012
Sex: M
Age:
State: PA

Vax Date: 01/04/2021
Onset Date: 01/04/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: slightly sore arm; This is a spontaneous report from a contactable Physician (reporting for himself). A 71-year-old male patient received BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, lot number: EK9231), via an unspecified route of administration on the left arm, at age 71 years first dose on 04Jan2021, at single dose for COVID-19 vaccination. Medical history included allergic to is seasonal from an unknown date and unknown if ongoing. There were no concomitant medications. On 04Jan2021, the patient had no reaction whatsoever, except a slightly sore arm. The outcome of the event was recovered on an unspecified date in Jan2021.

Other Meds:

Current Illness:

ID: 1062013
Sex: F
Age:
State: CA

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Fatigue; chills; severe aches; headache; nausea; dizziness; This is a spontaneous report from a contactable other healthcare professional. A 45-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) second dose, lot number: El9262, via an unspecified route of administration on 26Jan2021 15:00 at single dose in the left arm for COVID-19 immunization. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), lot number: En1686 on 05Jan2021 15:15 in the left arm. Medical history included allergy to bacteria. Concomitant medication included hydrochlorothiazide, triamterene (MAXZIDE), bupropion, escitalopram oxalate (LEXAPRO), lorazepam and paracetamol (TYLENOL). The patient previously took erythromycin and experienced drug allergies. The patient experienced fatigue, chills, severe aches, everywhere, headache, nausea, dizziness on 26Jan2021 at 22:00. No treatment received for the events. The patient had no prior vaccinations and has not tested for COVID post vaccination. The outcome of the events was not recovered.

Other Meds: MAXZIDE; BUPROPION; LEXAPRO; LORAZEPAM; TYLENOL

Current Illness:

ID: 1062014
Sex: F
Age:
State: HI

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Shortness of breath; heart palpitations; Muscle soreness (left arm); overall unwell feeling; This is a spontaneous report from a contactable consumer (patient). A 56-years-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EL 9262 and expiration date: unknown), via an unspecified route of administration on the left arm on 27Jan2021 at 09:15 at a single dose for COVID-19 immunization. Medical history included systemic lupus and shrimp allergies. The patient had no other vaccine in four weeks and no other medications in two weeks. There were no concomitant medications. The patient had no COVID prior vaccination. The patient experienced muscle soreness (left arm), heart palpitations, shortness of breath and overall unwell feeling on 27Jan2021 at 10:00, which resulted in a doctor or other healthcare professional office/clinic visit. No treatment was administered for the events. The patient has not tested for COVID post vaccination. The events were resolving.

Other Meds:

Current Illness:

ID: 1062015
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: pain and a calcium deposit on her shoulder; This is a spontaneous report from a contactable Other HCP (patient). A female patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE Solution for injection, lot no. and expiry date not reported), via an unspecified route of administration on unspecified date at a single dose for covid-19 immunization. Medical history included calcium deposit on her shoulder. The patient's concomitant medications were not reported. It was reported that she was scheduled to receive her second dose next week. She stated that she has pain and a calcium deposit on her shoulder, in which is on the opposite arm of injection site. She clarified that calcium deposit was there prior to receiving the vaccine and was not related to the vaccine. She stated that she was supposed to go to physical therapy and take steroids but was wondering if she should wait to take the steroids before the second injection. Patient asked if she can use antipyretics before or after vaccination and if there is a delay to receive the second dose, should it be minimum of 3 weeks. She stated she was told 17-22 days the second dose could be given. Outcome of the event was unknown.

Other Meds:

Current Illness:

ID: 1062016
Sex: M
Age:
State: PA

Vax Date: 12/22/2020
Onset Date: 12/30/2020
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Bilateral lower extremity numbness; Tingling; Foot pain; This is a spontaneous report from a contactable nurse (patient). A 44-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EJ1685), via an unspecified route of administration on the left arm, on 22Dec2020, at single dose, for covid-19 immunization. The patient has no medical history. Concomitant medication included ibuprofen. The patient received the vaccine on 22Dec2020 at the hospital. The patient was not diagnosed with COVID-19 prior vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 30Dec2020 18:00 sudden onset of bilateral lower extremity numbness, tingling, and foot pain. These continued to present day. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient received gabapentin as treatment for these adverse events. At the time of the report, the patient had not recovered from the adverse events. The patient has not been COVID-tested post-vaccination.

Other Meds: IBUPROFEN

Current Illness:

ID: 1062017
Sex: F
Age:
State: CO

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Breathing difficult; Chills; Body aches; Nauseous with and no appetite; Nauseous with and no appetite; Not feeling too well; One minute she was cold, and then one minute she was hot; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL330Z; Expiration date was not reported) on 26Jan2021 (08:45) at a single dose on the left deltoid (left shoulder area), with route of administration unspecified, for COVID-19 immunization. The patient had no relevant medical history and concomitant medications. The patient had previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EK8176; Expiration date was not reported) on 05Jan2021 (when the patient was 38 years old) for COVID-19 immunization. On 26Jan2021, after the second dose of vaccination, the patient was not feeling too well; had difficulty breathing; had chills; body aches; and was nauseous with no appetite. Along with the chills, the patient further stated that one minute she was cold, and then one minute she was hot on 26Jan2021. The patient did not receive any treatment for the reported events. The outcome of the events was not recovered for 'chills' and 'nauseous with and no appetite'; and was unknown for 'breathing difficult', 'body aches', 'not feeling too well' and 'one minute she was cold, and then one minute she was hot'.

Other Meds:

Current Illness:

ID: 1062018
Sex: F
Age:
State:

Vax Date: 01/16/2021
Onset Date: 01/19/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tired so quickly; Headache; back pain or the area of the lungs; like my asthma is worse; back pain or the area of the lungs; more like sore on the throat; Short of breath; coughing a few times; Throat pain; This is a spontaneous report from a contactable consumer (patient). A 50-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3249, expiration date unknown) via unspecified route of administration on left arm, on 16Jan2021, at a single dose for COVID-19 immunisation. The patient medical history included asthma. The concomitant medication were not reported. It was reported that on 19Jan2021, she had back pain, or the area of the lungs, headaches, throat pain, like more like sore on the throat, and she wasn't having too much coughing. She reported that initially she felt fine but 3 days later (19Jan2021), she began having shortness of breath "like my asthma is worse". She was coughing a few times, sporadically, not like one day coughing like crazy on 19Jan2021. On 26Jan2021, the patient tired so quickly even in her own place doing normal stuff, like cleaning and cooking. The patient used inhaler for short of breath which she usually did not use, like for year, and she saw it had already expired, and she got nervous that she saw it was expired, so she called her doctor to see if she could go, he said he was not receiving patients, all this stuff became so horrible. She tried to go to Urgent Care and they didn't see her, they said she had to go to the hospital, and she wanted to check her blood to see if she needs to receive the second shot or not, no one gave an answer, she doesn't know what to do, her second shot of vaccination was planned on 06Feb2021. Inhaler that was expired was Albuterol: expiry was Dec2020, lot DAEO68. During a call patient stated that the only symptom that worsened was short of breath. The patient wanted to know whether she could receive her second dose of vaccine. It was also reported that patient was not accepted in urgent care locations because she "may have covid" and was instructed to go to the ER (as reported). The patient assessed the events as non-serious. The patient was recovering from the events back pain or the area of the lungs, more like sore on the throat, coughing a few times, throat pain and headache and not recovered from other events.

Other Meds:

Current Illness:

ID: 1062019
Sex: F
Age:
State: RI

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Dizzy; This is a spontaneous report from a contactable consumer (patient herself). A 73-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: and expiry date were not reported), via an unspecified route of administration in the right arm on 27Jan2021 10:30 at a single dose "to not get the disease." Medical history included ongoing mood disorder and ongoing hypertension. Concomitant medication included alprazolam (XANAX) from Apr2020 for hypertension, valproate semisodium (DIVALPROEX) from Dec2020 as mood stabilizer, risperidone from Dec2020 as mood stabilizer and for hypertension, and amlodipine besilate from May2020 for blood pressure. The patient previously took alprazolam (XANAX) for hypertension and had been trying to wean herself because she was getting addicted to it. Alprazolam (XANAX) also made her dizzy and depressed. She also previously took escitalopram (LEXAPRO), fluoxetine (PROZAC), and Zoloft as antidepressants and stated that "they drove her crazier." The patient had no additional vaccines administered on same date of the Pfizer Suspect. The patient received that vaccine at housing complex where she resides and was looking at the list that she was given that had reactions. She was feeling dizzy on 27Jan2021 and wanted to know if she should be concerned. The patient reported that she will be speaking with her psychiatrist at 1:30pm during an online appointment asked if she should mention this to her. The event did not require visit to the emergency room or physician office. No relevant tests were conducted. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds: XANAX; DIVALPROEX; RISPERIDONE; AMLODIPINE BESILATE

Current Illness: Hypertension; Mood disorder

ID: 1062020
Sex: F
Age:
State: GA

Vax Date: 01/23/2021
Onset Date: 01/01/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Severe headache; Feeling unwell; Joint pains; Muscle pains; Difficulty breathing; Chest pain; Tiredness; She felt a "little bit of nausea, very slight"; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received the first dose of bnt162b2 (BNT162B2 also reported as PFIZER-BIONTECH COVID-19 VACCINE, lot EL3302), via an unspecified route of administration in the left arm on 23Jan2021 11:00 at single dose for Covid-19 immunisation. Medical history included blood pressure abnormal, thyroid disorder and high cholesterol. Concomitant medications included levothyroxine, lisinopril and rosuvastatin. The patient experienced severe headache, feeling unwell, joint pains, muscle pains, difficulty breathing, chest pain, tiredness on 24Jan2021 and little bit of nausea, very slight on unspecified date in Jan2021. The outcome of headache was recovered on 24Jan2021; for difficulty breathing was recovered; for chest pain and fatigue was recovering; for other events was unknown.

Other Meds: LEVOTHYROXINE; LISINOPRIL; ROSUVASTATIN

Current Illness:

ID: 1062021
Sex: M
Age:
State: DC

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: go for a walk and had onset of shortness of breath; little soreness in arm; This is a spontaneous report from a contactable consumer (patient himself). An 87-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; batch/lot/NDC number and expiration date were not provided), via an unspecified route of administration on 26Jan2021 at about 10:30 AM at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient reported that he received his first dose of Pfizer COVID-19 vaccine on 26Jan2021 about 10:30 AM at the hospital and he had no effects then. He had a little soreness in arm that night (26Jan2021), but woke up in the morning of the report date, on 27Jan2021 with no soreness in arm, and felt pretty good. Also, at the time of the report on 27Jan2021, he went out to go for a walk and had onset of shortness of breath. He waited a few minutes then continued to walk and still getting the shortness of breath. He called to ask if that was a normal side effect of the vaccine. The patient further indicated having "no problems," went for a walk and experienced shortness of breath. The patient recovered from the event "little soreness in arm" on 27Jan2021, while the outcome of the event "go for a walk and had onset of shortness of breath" was unknown. Information on the batch/lot number has been requested.

Other Meds:

Current Illness:

ID: 1062022
Sex: F
Age:
State: MD

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: tongue and lip tingling; subjective swelling; This is a spontaneous report from a contactable physician reported that a 37-years-old female patient first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number and expiration date were not reported) intramuscularly on 27Jan2021 at single dose for covid-19 immunisation. Medical history included anaphylaxis; nightshade vegetable allergy; Food allergy, migraine, Attention deficit hyperactivity disorder, anxiety, former smoker. Concomitant medication included amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL), alprazolam (XANAX), escitalopram oxalate (LEXAPRO), ethinylestradiol, norethisterone acetate (JUNEL), amitriptyline (AMITRIPTYLINE). The patient previously took atropine had anaphylaxis and known allergies. On 27Jan2021, patient developed tongue and lip tingling and subjective swelling within 10 minutes after vaccine administration. No angioedema. The patient was received treatment with benadryl, pepcid, IVF and solumedrol. Did the patient receive any other vaccines within 4 weeks prior to the COVID vaccine was unknown. Prior to vaccination, was the patient was not diagnosed with COVID-19; Since the vaccination, the patient not tested for COVID-19. The outcome of the events was recovered in 2021. Information on the lot/batch number has been requested.; Sender's Comments: Based on vaccine-event chronological association a causal relationship between events "tongue and lip tingling and subjective swelling" and BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Other Meds: ADDERALL; XANAX; LEXAPRO; JUNEL; AMITRIPTYLINE

Current Illness:

ID: 1062023
Sex: F
Age:
State: CA

Vax Date: 01/16/2021
Onset Date: 01/17/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: Test Date: 20210122; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptoms: Brain fog and fatigue, increased from first; Brain fog and fatigue, increased from first; Brain fog and fatigue, increased from first; Chills; shortness of breath with exertion; Palpitations; Paresthesias to bilateral hands and right foot/leg; Weakness to bilateral hands; This is a spontaneous report received from a contactable nurse (who is also the patient). A 39-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot number: ELB9B2, expiry date: unknown), intramuscular on the left arm, on 16Jan2021 12:00, at single dose, for COVID-19 immunization, at the hospital. Medical history included myelitis transverse from 2015, and depression. The patient has no known allergies. The patient was not pregnant at the time of vaccination. The patient did not have COVID-19 prior to vaccination. There were unspecified concomitant medications. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK5730, expiry date: unknown), intramuscular on the left arm, on 26Dec2020 11:30, for COVID-19 immunization and the patient experienced paresthesias to bilateral hands to elbows, right foot/leg with brain fog and fatigue. The patient did not receive other vaccines in four weeks. On 17Jan2021 at 07:00 (also reported as "12-18 hours after injection"), the patient experienced paresthesias to bilateral hands and right foot/leg; weakness to bilateral hands; brain fog and fatigue, increased from first; chills and shortness of breath with exertion; and palpitations. The events palpitations and shortness of breath with exertion were noticed on day 6 resulting to emergency room visit. It was also reported that the events resulted to emergency room and physician office visits. No treatment was given for the events. The patient was tested for COVID-19 post vaccination via nasal swab with negative result on 22Jan2021. The outcome of the events was recovering (improved gradually).

Other Meds:

Current Illness:

ID: 1062024
Sex: F
Age:
State: MA

Vax Date: 01/27/2021
Onset Date: 01/01/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Headache; pain at injection site; This is a spontaneous report from a contactable consumer (Patient). A 40-year-old female non-pregnant patient received first dose of bnt162b2 (formulation: Solution for injection, Brand: Pfizer, Lot number: unknown) via unspecified route of administration at 12:15 on 27Jan2021, on left arm at single dose for COVID-19 immunization. The patient medical history was not reported. The concomitant medication included CELEXA (celecoxib), NEXIUM (esomeprazole sodium) and ZYRTEC (cetirizine hydrochloride). It was reported that on an unknown date in Jan2021 at 07:00, the patient experienced headache and pain at injection site. The events were reported as non-serious by the reporter. The patient had not diagnosed with COVID-19 prior to vaccination and since the vaccination. It was reported that patient had no allergies to medications, food, or other products. The outcome of the events was not recovered. Information on the lot/batch number has been requested.

Other Meds: CELEXA [CELECOXIB]; NEXIUM [ESOMEPRAZOLE SODIUM]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]

Current Illness:

ID: 1062025
Sex: F
Age:
State: FL

Vax Date: 12/28/2020
Onset Date: 12/28/2020
Rec V Date: 03/01/2021
Hospital:

Lab Data: Test Date: 20201228; Test Name: COVID-19 test; Test Result: Negative ; Test Date: 20201230; Test Name: COVID-19 test; Test Result: Negative ; Test Date: 20210104; Test Name: COVID-19 test; Test Result: Negative ; Test Date: 20210108; Test Name: COVID-19 test; Test Result: Negative ; Test Date: 20210111; Test Name: COVID-19 test; Test Result: Negative ; Test Date: 20210114; Test Name: COVID-19 test; Test Result: Negative ; Test Date: 20210119; Test Name: COVID-19 test; Test Result: Negative ; Test Date: 20210125; Test Name: COVID-19 test; Test Result: Negative

Allergies:

Symptoms: Soreness in arm extending beyond injection site; Soreness in arm extending beyond injection site; Fatigue; This is a spontaneous report from a contactable healthcare professional (patient). This 37-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number EK5730) via an unspecified route of administration on 28Dec2020 (at the age of 37-years-old) as a single dose in the right arm for COVID-19 immunization. Medical history included hepatitis C. The patient was not pregnant at the time of vaccination. Prior to vaccination the patient was not diagnosed with COVID-19. Concomitant medications included buprenorphine, naloxone (SUBOXONE); bupropion (WELLBUTRIN); meloxicam; and lamotrigine (LAMICTAL); all from unknown dates for unspecified indications. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not have allergies to medications, food, or other products. On 28Dec2020 the patient experienced soreness in arm extending beyond the injection site and fatigue for 2 days. The events were reported as non-serious. The patient underwent lab tests and procedures which included COVID-19 tests on 28Dec2020, 30Dec2020, 04Jan2021, 08Jan2021, 11Jan2021, 14Jan2021, 19Jan2021, 25Jan2021 with results of negative. The patient did not receive treatment for the events. The events did not cause hospitalization. The outcome of soreness in arm extending beyond injection site was not recovered. The outcome of fatigue was recovered. No follow-up attempts are needed. No further information is expected.

Other Meds: SUBOXONE; WELLBUTRIN; MELOXICAM; LAMICTAL

Current Illness:

ID: 1062026
Sex: M
Age:
State: NY

Vax Date: 01/24/2021
Onset Date: 01/01/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: had a little muscle soreness; This is a spontaneous report from a non-contactable consumer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose, lot number and expiration date unknown, via an unspecified route of administration on 24Jan2021 at a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient received his vaccine on the 24th, four days ago. He only had a little muscle soreness and took Tylenol. He has another vaccine coming up next week. His next dose isn't until valentine's day. He asked if it was ok to get another vaccine between his doses. The outcome of the event was unknown. No follow-up attempts are possible; information on batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1062027
Sex: M
Age:
State: KY

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: stated that he developed confusion; experienced awful dreams; concentration to do normal things/it was too difficult to concentrate on the road and talk to her at the same time.; This is a spontaneous report from a contactable consumer (the patient). A 78-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL3249, expiry 31May2021), intramuscular in the left arm, on 27Jan2021 at 09:30 AM (at the age of 78 years) as a single dose for COVID-19 immunization. Medical history was none. Concomitant medication included ergocalciferol (VITAMIN D). The patient did not receive any other vaccines within four weeks prior to the vaccination. On 27Jan2021 he developed confusion, in which it took a lot of concentration to do normal things and he experienced awful dreams last night. The slight degree of confusion causing him to have to concentrate more than usual for ordinary tasks. The clinical outcome of the events he developed confusion, in which it took a lot of concentration to do normal things and he experienced awful dreams last night was recovering.

Other Meds: VITAMIN D [ERGOCALCIFEROL]

Current Illness:

ID: 1062028
Sex: F
Age:
State: CT

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Itching skin - Began on arms and legs but has extended to chest, face, scalp, back, etc.; No hives but itching and skin became red; hot in areas; Muscle soreness at injection site; This is a spontaneous report from a contactable consumer (patient). A 25-year-old female patient received the 1st dose of bnt162b2 (Pfizer-BioNTech COVID-19 Vaccine, Lot number: EL 3247), via an unspecified route of administration at the left arm on 27Jan2021 10:00 at SINGLE DOSE for covid-19 immunization. The vaccine was administered in a Workplace Clinic. The patient medical history was not reported. The patient was not pregnant at the time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient has not received any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medication included amoxicillin. The patient experienced Itching skin - began on arms and legs but has extended to chest, face, scalp, back, etc. No hives but itching and skin became red and hot in areas. Itching started around 12 hours post-dose. Muscle soreness at injection site - started approximately 12 hours post-dose. It was reported that event started on 27Jan2021 22:00. The events were assessed as non-serious, did not result in death, not life threatening, did not cause/prolonged hospitalization, not disabling/incapacitating, did not cause congenital anomaly/birth defect. Treatment was not received for the adverse events. The outcome of the events was not recovered.

Other Meds: AMOXICILLIN

Current Illness:

ID: 1062029
Sex: F
Age:
State: MO

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Soreness in arm, inability to lift above head; Soreness in arm, inability to lift above head; fatigue; minor nausea; This is a spontaneous report from a contactable consumer (patient). A 54-years-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number: EN5318 and expiration date unknown), via an unspecified route of administration on the right arm on 27Jan2021 08:30 at a single dose for COVID-19 immunization. Medical history included COVID-19; prior to vaccination, the patient was diagnosed with COVID-19. Concomitant medications included Vitamin D NOS and Multi-Vitamin. The patient previously took injectable Iodine and experienced drug allergy. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced soreness in arm - inability to lift above head, fatigue and minor nausea on 27Jan2021 at 13:00 (01:00 PM). No treatment was administered for the events. Since the vaccination, the patient has not been tested for COVID-19. The events were resolving.

Other Meds: VITAMIN D NOS

Current Illness:

ID: 1062030
Sex: F
Age:
State: OH

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: On day after had severe muscle ache; severe headache; nauseous; so cold (could not get warm); had a fever; slept for 15 hours; This is a spontaneous report from a contactable consumer. A 75-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: EL9265), via an unspecified route of administration on 26Jan2021 17:00 at single dose for covid-19 immunisation. Medical history included mitral valve prolapse and COVID-19. Concomitant medication included bimatoprost (LUMIGAN), colecalciferol (D3), zinc (ZINC), and ubidecarenone (COQ10). The patient experienced severe muscle ache, severe headache, nauseous, so cold (could not get warm), had a fever and slept for 15 hours on 26Jan2021 21:00. The patient received no treatment. The outcome of the events was recovered with sequelae on an unspecified date.

Other Meds: LUMIGAN; D3; ZINC; COQ10

Current Illness:

ID: 1062031
Sex: F
Age:
State: FL

Vax Date: 01/27/2021
Onset Date: 01/01/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Caller says she felt pain in her arm afterwards as well.; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE lot#:not provided), via an unspecified route of administration from on 27Jan2021 (at the age of 74-year-old) at SINGLE DOSE for COVID-19 immunization at the hospital and paracetamol (TYLENOL), via an unspecified route of administration and dates at 2 DF, daily (every morning) for aches and pains. Medical history and concomitant medications were not reported. The patient previously received the first dose of PFIZER-BIONTECH COVID-19 VACCINE (lot#: not provided) on an unknown date at SINGLE DOSE for COVID-19 immunization and says that she had no reaction to the first shot. The patient received the second dose and had a sore arm (in Jan2021) that was better today. She stated that in the morning she always took two paracetamol for aches and pains; and after she got the first and second shot she read three articles to do not take paracetamol before you get the vaccines as it might affect antibodies. However, no one published about this or said this at the hospital when she went to get the shot, they just asked what she was allergic to it. She would like to know if now she was not so protected because she took paracetamol and if this was a problem. The action taken in response with the adverse event for paracetamol was unknown. Outcome of the event was recovering Information on the lot/batch number has been requested.

Other Meds: TYLENOL ARTHRITIS

Current Illness:

ID: 1062032
Sex: F
Age:
State: FL

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: Test Date: 20210127; Test Name: heart beat; Result Unstructured Data: Test Result:rapid; Comments: Rapid heart beat for about an hour

Allergies:

Symptoms: Loose bowels 2nd day after shot; Rapid heart beat for about an hour second day, but could be thyroid as well; Rapid heart beat for about an hour second day, but could be thyroid as well; Sore arm, not severe; Lethargic for a day; This is a spontaneous report from a contactable other health professional, the patient. This 67-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: unknown), dose 1, single dose via an unspecified route of administration on 26Jan2021 at 09:00 AM in the left arm (at the age of 67 years-old) for COVID-19 vaccination. Medical history included hypothyroidism, autoimmune disease, allergies to penicillin and many foods. Concomitant medications included etanercept (ENBREL), levothyroxine sodium (SYNTHROID), liothyronine sodium (CYTOMEL) and losartan potassium (LOSARTIN). The patient receive did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 26Jan2021 at 09:00 AM, the patient experienced sore arm, not severe and was lethargic for a day. On 27Jan2021, the patient had loose bowels the second day after the shot and rapid heart beat for about an hour second day, but could be thyroid as well. No treatment was received for events, sore arm, lethargic, loose bowels, rapid heart beat and thyroid. The events were reported as non-serious. The clinical outcome of sore arm, lethargic, loose bowels, rapid heart beat and thyroid was recovering. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient has not been tested for COVID-19 since the vaccination. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Other Meds: ENBREL; SYNTHROID; CYTOMEL; LOSARTIN

Current Illness:

ID: 1062033
Sex: F
Age:
State: MD

Vax Date: 12/29/2020
Onset Date: 12/29/2020
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; night sweats; achy; chills; last menstrual date 19Dec2020 and first administration date=29Dec2020; This is a spontaneous report from a contactable nurse reporting for herself. A 31-year-old pregnant female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), lot number: EH9899, via an unspecified route of administration on 29Dec2020 at 13:00 (at the age of 31 years old) as a single dose in the left arm for COVID-19 immunisation. Medical history included seasonal allergies from an unknown date, acid reflux disease from an unknown date, headaches from an unknown date, and irritable bowel syndrome from an unknown date. Concomitant medication included pantoprazole sodium sesquihydrate (PROTONIX), prenatal vitamins, cetirizine hydrochloride (ZYRTEC), and unspecified allergy shot. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced headache on an unspecified date, night sweats on an unspecified date, achy on an unspecified date, chills on an unspecified date, and last menstrual date 19Dec2020 and first administration date of 29Dec2020. The mother was due to deliver on 25Sep2021. The patient did not receive treatment for the events. The outcome of the events headache, night sweats, achy and chills, and exposure during pregnancy was unknown. It was also reported that since the vaccination, the patient had not been tested for COVID-19.

Other Meds: PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]; ZYRTEC

Current Illness:

ID: 1062034
Sex: F
Age:
State: MI

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: petechiae; This is a spontaneous report from a contactable pharmacist (patient) reported that a female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on the arm on 27Jan2021 at a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. On 28Jan2021, the patient experienced 6 spots of petechiae on the inside of the arm that she received her vaccine. She stated that she got shot on outside of arm. The outcome of the event was unknown. Information on the lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1062035
Sex: F
Age:
State: NY

Vax Date: 01/24/2021
Onset Date: 01/24/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: headache; nauseous; soreness at the site; extreme fatigue; This is a spontaneous report from a contactable consumer (patient herself). A 71-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number: EN5318, expiration date was unknown), via an unspecified route of administration in the left arm on 24Jan2021 at 12:15 at a single dose for COVID-19 immunization. The vaccine facility type was reported as "other." Relevant medical history included hyperactive thyroid; known allergies to penicillin, eggs, and cashews; and severe allergy to all dairy products; all from an unknown date and unknown if ongoing. Concomitant medications included fluvastatin, ezetimibe (ZETIA), acetylsalicylic acid (BABY ASPIRIN), and unspecified multivitamins. The patient was not pregnant at the time of vaccination. The patient had no other vaccine in four weeks. The patient had no COVID prior vaccination. She had not tested for COVID post vaccination. On 24Jan2021, after 2-3 hours of receiving the vaccine, the patient became very nauseous, which lasted for three days. It had eased at the time of the report. On 24Jan2021, the patient also had soreness at the site, extreme fatigue, and headache. The patient had headache for about one day; however, she managed to deal with it without pain killer. The patient drank a lot of warm water with fresh ginger and lemon (with peel) to control the nausea. The patient was very fatigued for three days following the vaccine. Therapeutic measures were taken as a result of nauseous. The patient did not receive treatment for the events "soreness at the site, extreme fatigue, and headache." The patient was recovering from the events "nauseous, soreness at the site, extreme fatigue, and headache."

Other Meds: FLUVASTATIN; ZETIA; BABY ASPIRIN

Current Illness:

ID: 1062036
Sex: M
Age:
State: CA

Vax Date: 01/27/2021
Onset Date: 01/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Sore and stiff arm at injection site only; Sore and stiff arm at injection site only; This is a spontaneous report from a contactable consumer (patient). A 31-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot no: EN 5318, expiration date unknown), via an unspecified route of administration on left arm on 27Jan2021 at 11:45 AM at a single dose for COVID-19 immunization. Medical history included asthma, moderate to marked outdoor allergies. Allergies to medications, food, or other products was none. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), triamcinolone acetonide (NASACORT) and montelukast. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received other medications within 2 weeks of vaccination. The patient experienced Sore and stiff arm at injection site only on 26Jan2021 at 17:00. The patient assessed the events as non-serious. No treatment was received in response to the adverse event. The patient was not diagnosed with COVID-19 prior to vaccination. Since the vaccination, patient was not tested for COVID-19. The patient has not recovered from the events.

Other Meds: ALLEGRA; NASACORT; MONTELUKAST

Current Illness:

ID: 1062037
Sex: M
Age:
State: NY

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Stomach pain in right quadrant; This is a spontaneous report from a contactable healthcare professional (patient). A 29-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date not reported), via an unspecified route of administration on 27Jan2021 17:30 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced stomach pain in right quadrant on 28Jan2021 with outcome of not recovered. The patient did not receive any treatment for the event. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. Information of Lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1062038
Sex: F
Age:
State: CT

Vax Date: 01/26/2021
Onset Date: 01/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Pain at injection site; This is a spontaneous report from a contactable consumer (patient herself). A 32-year-old female patient received the first dose of BNT162B2 (Pfizer-BIONTECH COVID-19 Vaccine; Lot number: EL3247), via an unspecified route of administration in the left arm on 26Jan2021 at 11:45 as a single dose for COVID-19 immunisation. The patient's medical history was not reported. The patient was not pregnant at the time of vaccination. Concomitant medications included ibuprofen (ADVIL), paracetamol (TYLENOL), and multivitamins (unspecified); also reported as medications that the patient received within two weeks of vaccination. The patient previously took amoxicillin and Cefzil and experienced drug hypersensitivity. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine and was not diagnosed with COVID-19 prior to vaccination. The patient experienced pain at injection site on 27Jan2021. The patient has not tested positive for COVID-19 since the vaccination. The patient did not receive any treatment for the event. Outcome of the event was recovered. The case was reported as non-serious (did not result in death, was not life-threatening, did not cause/prolong hospitalization, was not disabling/incapacitating, and did not result to any congenital anomaly/birth defect).

Other Meds: ADVIL [IBUPROFEN]; TYLENOL

Current Illness:

ID: 1062039
Sex: F
Age:
State:

Vax Date: 01/27/2021
Onset Date: 01/28/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Swelling in the face; This is a spontaneous report from a non-contactable other health professional. A 52-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL9265), via an unspecified route of administration on 27Jan2021 (at the age of 52years) at single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant at the time of vaccination. It was unknown if the patient received any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced swelling in the face on 28Jan2021. There was no treatment received for the adverse event. The patient has not been tested for COVID-19 since the vaccination. The outcome of event was recovering. This case is non-serious. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1062040
Sex: F
Age:
State:

Vax Date: 01/26/2021
Onset Date: 01/26/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: Tingling sensation on her fingertips, on the lower part of her face, and chin; Tingling in her tongue and lip; This is a spontaneous report from a contactable nurse (patient). A 62-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, on 26Jan2021, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 for COVID-19 immunization. The patient received the second dose of the COVID-19 vaccine in the morning of 26Jan2021. From that afternoon on (26Jan2021), the patient had tingling in her tongue and lip. The patient did not have this side effect before. The patient was also feeling it on the lower part of her face today (28Jan2021) and is also feeling a tingling sensation on her fingertips. The patient was now (28Jan2021) experiencing a tingling sensation on her tongue, lips, and chin and it doesn't go. The patient wanted to speak with someone to ask if this is a normal side effect or if she should be concerned. The patient was asking what she can do about this. The patient had not recovered from the events. Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.

Other Meds:

Current Illness:

ID: 1062041
Sex: F
Age:
State: GA

Vax Date: 12/21/2020
Onset Date: 01/27/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data: Test Date: 20210127; Test Name: antibody test; Test Result: Negative

Allergies:

Symptoms: sore arm; I had an antibody test which was negative; This is a spontaneous report from a contactable physician. A 54-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number and expiration date were not reported), via an unspecified route of administration, first dose on 21Dec2020 and second dose on an unspecified date in 2021, both at single dose for COVID-19 immunisation. The patient medical history included chicken pox, she got those in the 1990s, probably in 1994-1995. The patient had unspecified concomitant medications. The patient stated, "I had an antibody test which was negative" on 27Jan2021. She says she had no symptoms other than a sore arm on an unspecified date, and then she had her antibodies checked and it is negative. She says she has no known immune deficiencies. The outcome of the events was unknown. Information of lot/batch number has been requested.

Other Meds:

Current Illness:

ID: 1062042
Sex: M
Age:
State: MI

Vax Date: 01/21/2021
Onset Date: 01/21/2021
Rec V Date: 03/01/2021
Hospital:

Lab Data:

Allergies:

Symptoms: itched everywhere ears, scalp legs and arms.; headache; tired; itchy nose; This is a spontaneous report from a contactable consumer (patient) A male patient of an unspecified age received BNT162B2 (Solution for injection, Lot/Batch number was not reported) via an unspecified route of administration on 21Jan2021 at single dose for covid-19 immunisation. The patient's medical history and concomitant medications was not reported. The patient received the first vaccine on 21Jan2021. He had a headache, tired and itchy nose. He took a benadryl and it went away. On 25Jan2021 that he itched everywhere ears, scalp legs and arms. The symptoms went away 30 minutes after Benadryl. The patient was not getting any better and maybe a little worse. The outcome of the events was recovered on an unspecified date of 2021.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 134,999

Page last modified: 14 December 2021 10:42pm